logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
E

Enrique Gómez-Gómez

department of urology
H指数:21
被引数:1,384

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

FGF23 blockade induces maladaptive vascular remodelling, reducing pathologically increased arterial stiffness and blood pressure

FGF23阻断诱导不良血管重塑，降低病理性升高的动脉僵硬度及血压

Nephrology Dialysis Transplantation
IF5.6
2026-09-240
OAAI
Raquel M García-Sáez; Ana I Torralbo-Romero; Rodrigo López-Baltanás; Antonio Rivas-Dominguez; Rafael Serrano-Berzosa; Teresa Obrero; Karen Valdes-Diaz; Daniel Jurado-Montoya; Enrique Gómez-Gómez; Juan P Campos-Hernandez; Michaela Lellig; Vera Jankowski; Joachim Jankowski; Miguel Fernández-Tenorio; Fernando Leiva-Cepas; María E Rodríguez-Ortiz; María V. Pendón Ruiz de Mier; Mariano Rodríguez; Cristian Rodelo-Haad; Juan R Muñoz-Castañeda; null
Prospective validation of a urine-based proteomics test for predicting clinically significant prostate cancer in biopsy-naïve patients

基于尿液的蛋白质组学检测预测活检初治患者临床显著前列腺癌的前瞻性验证

British Journal of Cancer
IF6.8
2026-08-290
PRE
Ana C. Morillo; Kirubel Nigusu Jobre; Guillermo Lendinez Cano; Ana Blanca-Pedregosa; Daniel Lopez Ruiz; Jose Parada; Isabel Heidegger; Zoran Culig; Antonio Lopez-Beltran; Julia Carrasco-Valiente; Harald Mischak; Rafael A. Medina; Juan P. Campos Hernandez; Maria Frantzi; Enrique Gómez Gómez
Multicenter Validation of a Risk Classification Cluster for Unfavorable Pathology in Prostatectomy Specimens of Patients with an Active Surveillance Expanded Inclusion Criteria

多中心验证适用于扩大纳入标准的主动监测患者的根治性前列腺切除标本中不良病理风险分类簇

Diagnostics
IF3.3
2026-07-030
OA
Maria Graus Romero; Cristobal Cobo Díaz; Guillermo Lendínez Cano; Laura Chamorro Castillo; Jorge Andres Gutiérrez Suarez; Juan Pablo Campos Hernández; Bernardo Herrera Imbroda; Rafael Angel Medina López; Enrique Gómez Gómez
miR-191–5p: A tumour suppressor miRNA and a personalized biomarker and potential therapeutic tool connecting prostate cancer and obesity

miR-191–5p: 一种肿瘤抑制miRNA，以及连接前列腺癌和肥胖的个性化生物标志物和潜在治疗工具

Biomedicine & Pharmacotherapy
IF7.5
2025-07-050
PRE
Francisco Porcel-Pastrana; Antonio J. Montero-Hidalgo; Vicente Herrero-Aguayo; Prudencio Sáez-Martínez; Jesús M. Perez-Gómez; André Sarmento-Cabral; Juan P. Campos-Hernández; Oriol A. Rangel-Zuñiga; Julia Carrasco-Valiente; Antonio J. Martínez-Fuentes; Manuel D. Gahete; Enrique Gómez-Gómez; Raúl M. Luque
Multicenter External Validation and Optimization of a Proposed Nomogram for Prostate-Specific Membrane Antigen PET/CT Accuracy in Biochemical Recurrence

多中心外部验证与优化：针对前列腺特异性膜抗原 PET/CT 在生化复发中准确性的提议列线图的验证与优化

PROSTATE
IF2.5
2025-05-060
PRE
Castillo, Laura Chamorro; Belenchon, Ines Rivero; Sanz, Ignacio Puche; Marenco, Rocio Saiz; Claro, Ana Victoria Ojeda; Martinez, Nestor Sanchez; Lopez, Rafael Medina; Soto, Alvaro Juarez; Ossorio, Jose Luis Alvarez; Galisteo, Emilio Garcia; Valiente, Julia Carrasco; Imbroda, Bernardo Herrera; Jimenez, Juan Moreno; Casas, Juan Antonio Vallejo; Rodriguez, Antonio; Ortiz, Adrian Santiago; Hernandez, Juan Pablo Campos; Gomez, Enrique Gomez
Prediction of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy by Collagen Models Using Multiomic Profiles

Frantzi M, Tymoszuk P, Salcher S, Gomez-Gomez E, Morillo AC, Melchior F, et al. 通过胶原蛋白模型和多组学谱预测根治性前列腺切除术后前列腺癌的生物化学复发。欧洲泌尿肿瘤学杂志。(2025)。doi: 10.1016/j.euo.2025.03.016

European Urology Oncology
IF9.3
2025-05-010
OAAI
Maria Frantzi; Piotr Tymoszuk; Stefan Salcher; Enrique Gomez-Gomez; Ana C. Morillo; Felix Melchior; Ana Blanca; Harald Mischak; Antonia Vlahou; Andreas Pircher; Isabel Heidegger
Prognostic Significance of Programmed Cell Death-1, Programmed Cell Death-Ligand 1, Programmed Cell Death-Ligand 2, and Fibroblast Growth Factor Receptor 3 mRNA Expression in Bladder Cancer

膀胱癌中程序性细胞死亡因子1、程序性细胞死亡因子配体2和成纤维细胞生长因子受体3 mRNA表达的预后意义

PATHOBIOLOGY
IF2
2025-02-260
PRE
Blanca, Ana; Lopez-Beltran, Antonio; Gomez-Gomez, Enrique; Campos-Hernandez, Pablo; Cimadamore, Alessia; Montironi, Rodolfo; Cheng, Liang
SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancer
SCIENCE ADVANCES
IF12.5
2024-10-041
OAAI
Montero-Hidalgo, Antonio J.; Jimenez-Vacas, Juan M.; Gomez-Gomez, Enrique; Porcel-Pastrana, Francisco; Saez-Martinez, Prudencio; Perez-Gomez, Jesus M.; Fuentes-Fayos, Antonio C.; Blazquez-Encinas, Ricardo; Sanchez-Sanchez, Rafael; Gonzalez-Serrano, Teresa; Castro, Elena; Lopez-Soto, Pablo J.; Carrasco-Valiente, Julia; Sarmento-Cabral, Andre; Martinez-Fuentes, Antonio J.; Eyras, Eduardo; Castano, Justo P.; Sharp, Adam; Olmos, David; Gahete, Manuel D.; Luque, Raul M.
Lower baseline testosterone level is related to earlier development of castration resistance in metastatic prostate cancer: a multi-center cohort study

较低的基线睾酮水平与转移性前列腺癌去势抵抗的早期发展有关: 一项多中心队列研究

FRONTIERS IN ONCOLOGY
IF3.3
2024-02-200
OAAI
Wong, Ho Ming Chris; Chiu, Peter Ka-Fung; Puche-Sanz, Ignacio; Xue, Zhao; Chen, Dong-Ning; Gomez-Gomez, Enrique; Heidegger, Isabel; Kafka, Mona; Wei, Yong; Sakamoto, Shinichi; Ng, Anthony Chi Fai
Tumor suppressor role of RBM22 in prostate cancer acting as a dual-factor regulating alternative splicing and transcription of key oncogenic genes
TRANSLATIONAL RESEARCH
IF5.9
2023-03-017
OAAI
Jimenez-Vacas, Juan M.; Montero-Hidalgo, Antonio J.; Gomez-Gomez, Enrique; Saez-Martinez, Prudencio; Fuentes-Fayos, Antonio C.; Closa, Adria; Gonzalez-Serrano, Teresa; Martinez-Lopez, Ana; Sanchez-Sanchez, Rafael; Lopez-Casas, Pedro P.; Sarmento-Cabral, Andre; Olmos, David; Eyras, Eduardo; Castano, Justo P.; Gahete, Manuel D.; Luque, Raul M.

研究方向

暂未获取到该数据
R
Raúl M. Luque
H 指数:55论文数:528被引数:9,384
M
Manuel D. Gahete
H 指数:42论文数:332被引数:5,066
J
Juan M. Jiménez‐Vacas
H 指数:19论文数:180被引数:1,263
J
Justo P. Castaño
H 指数:54论文数:461被引数:1.0万
A
Antonio J. Montero‐Hidalgo
H 指数:11论文数:49被引数:389
P
Prudencio Sáez-Martínez
H 指数:9论文数:40被引数:349
A
Ana Blanca
H 指数:26论文数:83被引数:1,951
R
Rafael Sánchez‐Sánchez
H 指数:18论文数:51被引数:1,097
J
Julia Carrasco‐Valiente
H 指数:15论文数:90被引数:717
V
Vicente Herrero‐Aguayo
H 指数:13论文数:36被引数:493